KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma. Gallina FT, Marinelli D, Melis E, Forcella D, et al. Lung Cancer 2023;181:107254.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gallina FT, Marinelli D, Melis E, Forcella D, et al. KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma. Lung Cancer 2023;181:107254.
PMID: 37253296